After controlling for variables such as other patient demographics, geography or type of diagnosis, First Nations status was the only apparent explanation for the difference.
Although treatments can often seem standard and straightforward, the more we know about the patient, the better our chance of helping them to achieve successful outcomes.
Diltiazem used for ventricular rate control in patients with atrial fibrillation inhibits apixaban and rivaroxaban elimination, possibly causing overanticoagulation.
